OTC drugs of abuse test kits must stress need for positive result confirmation -- cmte.
This article was originally published in The Tan Sheet
Executive Summary
OTC DRUGS OF ABUSE TESTS NEED FOR PRESUMPTIVE-POSITIVE CONFIRMATION must be conveyed to consumers on product labeling as a means of backing up positive or potentially positive test results, FDA's Clinical Chemistry and Toxicology Devices Panel suggested at its Sept. 25 meeting in Bethesda, Md. "FDA should spell out instructions for confirmatory testing in such a way that [labeling would convey] why confirmatory testing needs to be done," said consultant James Everrett, MD/PhD, Morehouse School of Medicine, Atlanta.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning